Table 1.
Symptoms of HZ/PHN reported, by group
| Symptom | Spontaneously reported | Reported overall | Reported as reason for seeking diagnosisa | Reported post-acute phase | Ranked as most bothersome |
|---|---|---|---|---|---|
| Group A1, HZ 7–30 days (n = 8) | |||||
| Rash | 8 (100%) | 8 (100%) | 8 (100%) | – | 1 (13%) |
| Pain | 8 (100%) | 8 (100%) | 8 (100%) | – | 5 (63%) |
| Fatigue | 7 (88%) | 7 (88%) | 1 (20%) | – | – |
| Itchiness/dryness | 6 (75%) | 6 (75%) | 1 (13%) | – | 2 (25%) |
| Headaches | 5 (63%) | 5 (63%) | 3 (38%) | – | 1 (13%) |
| Tingling | 2 (25%) | 2 (25%) | 2 (25%) | – | – |
| Pinching | 2 (25%) | 2 (25%) | 1 (13%) | – | – |
| Fever | 1 (13%) | 1 (13%) | 1 (13%) | – | – |
| Muscle spasms | 1 (13%) | 1 (13%) | 1 (13%) | – | – |
| Numbness and tingling | 1 (13%) | 1 (13%) | – | – | – |
| Swelling | 1 (13%) | 1 (13%) | – | – | – |
| Group A2, HZ 31–60 days (n = 10) | |||||
| Rash | 10 (100%) | 10 (100%) | 10 (100%) | – | 2 (20%) |
| Pain | 8 (80%) | 9 (90%) | 9 (90%) | – | 7 (70%) |
| Fatigue | 9 (90%) | 9 (90%) | 2 (20%) | – | – |
| Itchiness/dryness | 6 (60%) | 6 (60%) | 6 (60%) | – | 2 (20%) |
| Numbness and tingling | 2 (20%) | 2 (20%) | – | – | – |
| Headaches | 2 (20%) | 2 (20%) | 1 (10%) | – | – |
| Lack of sensation | 2 (20%) | 2 (20%) | – | – | – |
| Vision problems | 2 (20%) | 2 (20%) | – | – | 1 (10%) |
| Fever | 2 (20%) | 2 (20%) | 2 (20%) | – | – |
| Eye irritation | 1 (10%) | 1 (10%) | 1 (10%) | – | 1 (10%) |
| Tingling | 1 (10%) | 1 (10%) | 1 (10%) | – | – |
| Chills | 1 (10%) | 1 (10%) | 1 (10%) | – | – |
| Muscle aches | 1 (10%) | 1 (10%) | – | – | – |
| Tenderness | 1 (7%) | 1 (7%) | – | – | – |
| Group B, PHN (n = 14) | |||||
| Rash | 14 (100%) | 14 (100%) | 14 (100%) | 5 (36%) | 1 (7%) |
| Pain | 14 (100%) | 14 (100%) | 14 (100%) | 7 (50%) | 9 (64%) |
| Fatigue | 8 (57%) | 10 (71%) | 3 (21%) | 6 (43%) | 1 (7%) |
| Itchiness/dryness | 7 (50%) | 8 (57%) | 4 (29%) | 3 (21%) | 3 (21%) |
| Headaches | 3 (21%) | 3 (21%) | 2 (14%) | 1 (7%) | 2 (14%) |
| Tenderness | 3 (21%) | 4 (29%) | – | 4 (29%) | – |
| Numbness and tingling | 3 (21%) | 3 (21%) | – | 3 (21%) | – |
| Weakness | 2 (14%) | 2 (14%) | – | – | – |
| Fever | 2 (14%) | 2 (14%) | – | – | – |
| Vision problems | 1 (7%) | 1 (7%) | – | – | 1 (7%) |
| Seasick-like symptoms | 1 (7%) | 1 (7%) | 1 (7%) | – | – |
HZ herpes zoster, PHN postherpetic neuralgia
aPatients were asked about what led them to seek diagnosis, although they may have presented with additional symptoms prior to diagnosis